Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: A preliminary study

International Urology and Nephrology

Volumn 39, Issue 4, 2007, Pages 1147-1152

  Song, Yun Seob ^a   Ku, Ja Hyeon ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Alpha blocker; Bladder; IPSS; Nocturia; Urination disorders; Zolpidem

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TAMSULOSIN; TERAZOSIN; ZOLPIDEM;

ADULT; AGED; ARTICLE; ATAXIA; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COHORT ANALYSIS; CONFUSION; CONTROLLED STUDY; DIZZINESS; DROWSINESS; DRUG EFFICACY; EVENING DOSAGE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; MONOTHERAPY; NIGHTMARE; NOCTURIA; PATIENT SELECTION; PSYCHOMOTOR DISORDER; PSYCHOSIS; QUALITY OF LIFE INDEX; REFERENCE VALUE; SCORING SYSTEM; SENSORY DYSFUNCTION; SLURRED SPEECH; TACHYCARDIA; TASTE DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UROFLOWMETRY;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MIDDLE AGED; PRAZOSIN; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PYRIDINES; QUALITY OF LIFE; STATISTICS, NONPARAMETRIC; SULFONAMIDES; TREATMENT OUTCOME; URINATION DISORDERS; URODYNAMICS;

EID: 36649030339     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-007-9206-x     Document Type: Article

References (36)

1. van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179-183
2. Asplund R, Aberg H (1992) Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care 10:98-104
3. Yoshimura K, Ohara H, Ichioka K et al (2003) Nocturia and benign prostatic hyperplasia. Urology 61:786-790
4. Homma Y, Yamaguchi T, Kondo Y et al (2002) Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia. J Urol 167:172-176
5. Bruskewitz RC, Larsen EH, Madsen PO et al (1986) 3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol 136:613-615
6. Larsson G, Victor A (1988) Micturition patterns in a healthy female population, studied with a frequency/volume chart. Scand J Urol Nephrol Suppl 114:53-57
7. Abrams P, Klevmark B (1996) Frequency volume charts. An indispensable part of lower urinary tract assessment. Scand J Urol Nehrol Suppl 179:47-53
8. Larsson G, Abrams P, Victor A (1998) The frequency/volume chart in detrusor instability. Neurourol Urodyn 1:533-543
9. Robinson D, McClish DK, Wyman JF et al (1996) Comparison between urinary diaries completed with and without intensive patient instructions. Neurourol Urodyn 15:143-148
10. Weiss JP, Blaivas JG, Stember DS et al (1998) Nocturia in adults: etiology and classification. Neurourol Urodyn 17:467-472
11. Ku JH, Jeong IG, Lim DJ et al (2004) Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: Prospective assessment of patient compliance and burden. Neurourol Urodyn 23:331-335
12. Drake MJ, Mills IW, Noble JG (2004) Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 171:1199-1202
13. Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: Three simple indices to define bladder voiding function. BJU Int 84:14-15
14. Hodgson LA (1991) Why do we need sleep? Relating theory to nursing practice. J Adv Nurs 16:1503-1510
15. Nicolau MC, Akaarir M, Gamundi A et al (2000) Why we sleep: The evolutionary pathway to the mammalian sleep. Prog Neurobiol 62:379-406
16. Sejnowski TJ, Destexhe A (2000) Why do we sleep? Brain Res 886:208-223
17. Broman JE, Lundh LG, Hetta J (1996) Insufficient sleep in the general population. Neurophysiol Clin 20:30-39
18. Middelkoop HA, Smulde-van den Doel DA, Neven AK et al (1996) Subjective sleep characteristics of 1485 males and females aged 50-93: Effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol Biol Sci Med Sci 51:M108-M115
19. Benca RM (2005) Diagnosis and treatment of chronic insomnia: A review. Psychiatr Serv 56:332-343
20. Walsh JK, Erman M, Erwin CW et al (1998) Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia. Hum Psychopharmacol 13:191-198
21. Scharf MB, Roth T, Vogel GW et al (1994) A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 55:192-199
22. Walsh JK, Roth T, Randazzo A et al (2000) Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 23:1087-1096
23. Perlis ML, McCall WV, Krystal AD et al (2004) Longterm, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. Clin Psychiatry 65:1128-1137
24. Kummer J, Guendel L, Linden J et al (1993) Long-term polysomnographic study of the efficacy and safety of zolpidem in elderly psychiatric in-patients with insomnia. J Int Med Res 21:171-184
25. Asnis GM, Chakraburtty A, DuBoff EA et al (1999) Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry 60:668-676
26. Schlich D, L'Heritier C, Coquelin JP et al (1991) Long-term treatment of insomnia with zolpidem: A multicentre general practitioner study of 107 patients. J Int Med Res 19:271-279
27. Matthiesen T, Rittig S, Norgaard JP et al (1996) Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol 156:1292-1299
28. Paick JS, Ku JH, Shin JW et al (2006) alpha-blocker monotherapy in the treatment of nocturia in men with lower urinary tract symptoms: A prospective study of response prediction. BJU Int 97:1017-1023
29. Tanaka Y, Masumori N, Itoh N et al (2002) Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia. J Urol 167:2492-2495
30. Okada H, Kamidono S, Yoshioka T et al (2000) A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients. BJU Int 85:676-681
31. Lee E, Lee C (1997) Clinical comparison of selective and non-selective alpha 1Aadrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses. Br J Urol 80:606-611
32. McConnell JD, Barry MJ, Bruskewitz RC et al (1994) Benign Prostatic Hyperplasia: Diagnosis and treatment. Clinical practice guideline, no. 8. AHCPR publication no. 94-0582. Rockville, MD, Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services
33. Hansen BJ, Meyhoff HH, Nordling J et al (1996) Placebo effects in the pharmacological treatment of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol 30:373-377
34. Reynard JM, Cannon A, Yang Q et al (1998) A novel therapy for nocturnal polyuria: A double-blind randomized trial of frusemide against placebo. Br J Urol 81:215-218
35. Mattiasson A, Abrams P, Van Kerrebroeck P et al (2002) Efficacy of desmopressin in the treatment of nocturia: A double-blind placebocontrolled study in men. BJU Int 89:855-862
36. Asplund R, Sundberg B, Bengtsson P (1999) Oral desmopressin for nocturnal polyuria in elderly subjects: A doubleblind, placebo-controlled randomized exploratory study. BJU Int 83:591-595